Range
0.71 - 0.73
Vol / Avg.
311.2K/2.3M
Div / Yield
-
52 Wk
0.29 - 3.62
Mkt Cap
86.2M
Payout Ratio
-
Open
0.72
P/E
-
EPS
-0.02
Shares
121.2M
Outstanding
121.2M
Total Float
121.2M
load more
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.020
REV600.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AEZSAEterna Zentaris-3.04%86.2M

AEterna Zentaris Frequently Asked Questions

Q

How do I buy AEterna Zentaris (AEZS) stock?

A

You can purchase shares of AEterna Zentaris (NASDAQ: AEZS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AEterna Zentaris's (AEZS) competitors?

A

There are no as such competitors for AEterna Zentaris.

Q

What is the target price for AEterna Zentaris (AEZS) stock?

A

The latest price target for AEterna Zentaris (NASDAQ: AEZS) was reported by Maxim Group on June 15, 2018. The analyst firm set a price target for 0.00 expecting AEZS to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AEterna Zentaris (AEZS)?

A

The stock price for AEterna Zentaris (NASDAQ: AEZS) is $0.7118 last updated Today at 4:59:00 PM.

Q

Does AEterna Zentaris (AEZS) pay a dividend?

A

There are no upcoming dividends for AEterna Zentaris.

Q

When is AEterna Zentaris (NASDAQ:AEZS) reporting earnings?

A
AEterna Zentaris’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is AEterna Zentaris (AEZS) going to split?

A

There is no upcoming split for AEterna Zentaris.

Q

What sector and industry does AEterna Zentaris (AEZS) operate in?

A

AEterna Zentaris is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.